The news that the University of Oxford has developed a COVID-19 vaccine that appears safe and has triggered an immune response is an encouraging step in our long journey toward returning to normality. It also provides the opportunity to join forces to tackle the pandemic and highlight Africa’s scientific leadership. This according to the University of Cape Town’s (UCT) Professor Kelly Chibale.
The news that the University of Oxford has developed a Covid-19 vaccine, that appears safe and has triggered an immune response, is an encouraging step in our long journey toward returning to normality. It also provides the opportunity to join forces to tackle the pandemic and highlight Africa’s scientific leadership.
When South Africa’s first Covid-19 case was confirmed in early March 2020, few could have predicted what would come next. Fast forward to July 2020 and we are leading in a tally that we would rather not be placed in: South Africa has the highest number of Covid-19 cases on the continent – accounting for just over half of Africa’s almost 900,000 cases. More than 7,000 families have lost a loved one, although some experts believe this number could be higher.
But how we are affected goes beyond these numbers. In March 2020, you wouldn’t have thought twice about hugging a friend or an elderly relative. Now you hold back, unsure of the risk. And, of course, there is the cost to the economy: Scores of people have lost their jobs, with thousands fighting for the few that remain.
Physical distancing and the restrictions put in place by the government have been crucial in helping us manage the pandemic, but we can’t stay distanced forever.
That’s why the news around the University of Oxford vaccine is so welcome. Never before have we seen such encouraging results so early in the process. While we still have a long way to go before we arrive at a safe and effective vaccine, these results give us hope that a vaccine is possible, and we are on the right path.
Building on these initial results, the Oxford trial will now move to expand the number of participants to ensure the results can be repeated across regions and help identify any potential side effects. South Africa is one of four countries where clinical trials are being held. This is happening as scientists across continents join forces in an array of other vaccine trials. A final vaccine, albeit not guaranteed, may still be many months, (or possibly even years) away, but when it arrives, we can be assured it will be safe and effective.
I have dedicated my career to researching and finding solutions to some of the continent’s most stubborn diseases like malaria and tuberculosis. But never before have I seen so much interest or focus on health science and research. At the same time, we have to debunk misinformation and conspiracy theories. Sometimes, it can be an innocent mistake; misinformation spreads so easily because it taps into our fears and doesn’t need to include any truths. But the impact can be dangerous and damaging.
First, it perpetuates the belief that Africa can’t be a source of health innovation. Second, it could discourage the next generation of researchers – why dedicate your life to science and finding solutions for someone on the internet to dispute your work and sometimes even slander you?
“Every day, I interact with some of the biggest and brightest scientific minds. And it isn’t just in South Africa. Across the continent, there is a cadre of scientists working on solutions to some of Africa’s biggest problems. It is time we celebrated and amplified our scientific expertise. It is time we became more active participants in the global scientific community.”
More than ever, we need to encourage dialogue between scientists and our communities, and share the tremendous benefits of science. Covid-19 has provided us with a golden opportunity to contribute to and participate in a global priority. It is also essential. Africa is genetically the most diverse continent on Earth. We need to ensure that the different regions in Africa are part of clinical trials, so that a vaccine, as well as its dosage and frequency, is tailored for the use of our specific populations, rather than being brought in from the global North.
Currently, fewer than 2% of clinical trials globally are conducted in Africa. We need to change this and ensure that African perspectives are considered during the clinical testing of medicines and vaccines. By being active participants, we can help ensure vaccines and treatments will work here. It also gives us capital to demand equal and early access to successful vaccines.
But it also goes beyond this, to something much bigger. We are experiencing a global pandemic, the like of which has not been seen in over a century. Helping find the solution allows us to build our research institutions and capacity, which, in turn, helps better prepare our infrastructure for future pandemics and creates jobs.
Clinical research requires the services of scientists, nurses and technologists to name a few, so you can imagine the array of meaningful, knowledge-based opportunities they can create for young Africans not just in direct jobs, but also in indirect jobs. As somebody who grew up in townships and villages, I can vouch for the power of a science-driven job to change the life of a young person.
It is also our responsibility to get involved. As Africans, we cannot demand equitable access or distribution of a vaccine if we do not participate and contribute ourselves. This is an opportunity for African scientists to lead, to earn respect and credibility, and to show that we can be at the forefront of doing clinical trials.
Every day, I interact with some of the biggest and brightest scientific minds. And it isn’t just in South Africa. Across the continent, there is a cadre of scientists working on solutions to some of Africa’s biggest problems. It is time we celebrated and amplified our scientific expertise. It is time we became more active participants in the global scientific community.
As scientists across the world continue their work, I call upon all citizens in Africa to become partners in the quest for a Covid-19 vaccine. Only through our joint efforts and trust in science can this virus be defeated.
COVID-19 is a global pandemic that caused President Cyril Ramaphosa to declare a national disaster in South Africa on 15 March and implement a national lockdown from 26 March.
UCT is taking the threat of infection in our university community extremely seriously, and this page will be updated regularly with the latest COVID-19 information.
Getting credible, evidence-based, accessible information and recommendations relating to COVID-19
The Department of Medicine at the University of Cape Town and Groote Schuur Hospital, are producing educational video material for use on digital platforms and in multiple languages. The information contained in these videos is authenticated and endorsed by the team of experts based in the Department of Medicine. Many of the recommendations are based on current best evidence and are aligned to provincial, national and international guidelines. For more information on UCT’s Department of Medicine, please visit the website.
To watch more videos like these, visit the Department of Medicine’s YouTube channel.
As the COVID-19 crisis drags on and evolves, civil society groups are responding to growing and diversifying needs – just when access to resources is becoming more insecure, writes UCT’s Prof Ralph Hamann.
03 Jul 2020 - 6 min read RepublishedThe Covid-19 crisis has reinforced the global consequences of fragmented, inadequate and inequitable healthcare systems and the damage caused by hesitant and poorly communicated responses.
24 Jun 2020 - >10 min read OpinionOur scientists must not practise in isolation, but be encouraged to be creative and increase our knowledge of the needs of developing economies, write Professor Mamokgethi Phakeng, vice-chancellor of UCT, and Professor Thokozani Majozi from the University of the Witwatersrand.
09 Jun 2020 - 6 min read RepublishedSouth Africa has been recognised globally for its success in flattening the curve, which came as a result of President Ramaphosa responding quickly to the crisis, writes Prof Alan Hirsch.
28 Apr 2020 - 6 min read RepublishedIn an email to the UCT community, Vice-Chancellor Professor Mamokgethi Phakeng said:
“COVID-19, caused by the virus SARS-CoV-2, is a rapidly changing epidemic. [...] Information [...] will be updated as and when new information becomes available.”
We are continuing to monitor the situation and we will be updating the UCT community regularly – as and when there are further updates. If you are concerned or need more information, students can contact the Student Wellness Service on 021 650 5620 or 021 650 1271 (after hours), while staff can contact 021 650 5685.